Group One Trading’s Vir Biotechnology VIR Stock Holding History

Group One Trading’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,554	Closed	-$28.3K	–	8838
2025 Q4	$21.4K	Buy	+3,554	New	+$21.2K	﹤0.01%	6292
2025 Q3	–	Sell	-13,967	Closed	-$71.4K	–	9221
2025 Q2	$70.4K	Buy	13,967 +3,085	+28%	+$16.5K	﹤0.01%	5275
2025 Q1	$70.5K	Sell	10,882 -168,380	-94%	-$1.5M	﹤0.01%	4889
2024 Q4	$1.32M	Buy	+179,262	New	+$1.41M	﹤0.01%	2298
2023 Q4	–	Sell	-38,739	Closed	-$354K	–	8253
2023 Q3	$363K	Buy	38,739 +28,314	+272%	+$404K	﹤0.01%	3248
2023 Q2	$256K	Buy	+10,425	New	+$262K	﹤0.01%	3681
2022 Q2	–	Sell	-12,293	Closed	-$287K	–	8581
2022 Q1	$316K	Sell	12,293 -519	-4%	-$15.4K	﹤0.01%	4319
2021 Q4	$536K	Buy	+12,812	New	+$502K	﹤0.01%	4058
2021 Q3	–	Sell	-11,417	Closed	-$494K	–	8839
2021 Q2	$540K	Buy	+11,417	New	+$519K	﹤0.01%	4138
2020 Q4	–	Sell	-368	Closed	-$12K	–	7045
2020 Q3	$13K	Buy	+368	New	+$15.8K	﹤0.01%	5329

Other funds holding VIR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GSK plc London $602M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Group One Trading's VIR Position: Q1 2026 in Review

Group One Trading sold out of Vir Biotechnology (VIR) in Q1 2026, closing a stake of 3,554 shares — an estimated $28.3K sold.

Group One Trading first reported a position in VIR in Q3 2020 and held it in 10 quarters. The position peaked at $1.32M in Q4 2024. 252 funds tracked by Wall St. Rank hold VIR as of Q1 2026.

Group One Trading reported no remaining Vir Biotechnology position as of Q1 2026 after selling out during the quarter.
Group One Trading sold 3,554 Vir Biotechnology shares in Q1 2026, an estimated $28.3K.
Group One Trading first reported a position in Vir Biotechnology in Q3 2020 and held it in 10 quarters.
Group One Trading's Vir Biotechnology position peaked at $1.32M in Q4 2024.
252 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.